Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Harpoon Therapeutics stock | $6.42

Learn how to easily invest in Harpoon Therapeutics stock.

Harpoon Therapeutics Inc is a biotechnology business based in the US. Harpoon Therapeutics shares (HARP) are listed on the NASDAQ and all prices are listed in US Dollars. Harpoon Therapeutics employs 88 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Harpoon Therapeutics

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – HARP – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Harpoon Therapeutics stock price (NASDAQ: HARP)

Use our graph to track the performance of HARP stocks over time.

Harpoon Therapeutics shares at a glance

Information last updated 2021-10-23.
Latest market close$6.42
52-week range$6.32 - $25.24
50-day moving average $7.81
200-day moving average $13.59
Wall St. target price$28.10
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-3.61

Buy Harpoon Therapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Harpoon Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Harpoon Therapeutics price performance over time

Historical closes compared with the close of $6.42 from 2021-10-22

1 week (2021-10-18) -3.89%
1 month (2021-09-24) -19.35%
3 months (2021-07-23) -44.13%
6 months (2021-04-23) -68.73%
1 year (2020-10-23) -58.15%
2 years (2019-10-24) -51.66%
3 years (2018-10-21) N/A
5 years (2016-10-21) N/A

Harpoon Therapeutics financials

Revenue TTM $26.2 million
Gross profit TTM $-35,121,000
Return on assets TTM -17.06%
Return on equity TTM -126.7%
Profit margin 0%
Book value $2.79
Market capitalisation $209.7 million

TTM: trailing 12 months

Shorting Harpoon Therapeutics shares

There are currently 831,979 Harpoon Therapeutics shares held short by investors – that's known as Harpoon Therapeutics's "short interest". This figure is 45.4% down from 1.5 million last month.

There are a few different ways that this level of interest in shorting Harpoon Therapeutics shares can be evaluated.

Harpoon Therapeutics's "short interest ratio" (SIR)

Harpoon Therapeutics's "short interest ratio" (SIR) is the quantity of Harpoon Therapeutics shares currently shorted divided by the average quantity of Harpoon Therapeutics shares traded daily (recently around 426655.8974359). Harpoon Therapeutics's SIR currently stands at 1.95. In other words for every 100,000 Harpoon Therapeutics shares traded daily on the market, roughly 1950 shares are currently held short.

However Harpoon Therapeutics's short interest can also be evaluated against the total number of Harpoon Therapeutics shares, or, against the total number of tradable Harpoon Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Harpoon Therapeutics's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Harpoon Therapeutics shares in existence, roughly 30 shares are currently held short) or 0.0273% of the tradable shares (for every 100,000 tradable Harpoon Therapeutics shares, roughly 27 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Harpoon Therapeutics.

Find out more about how you can short Harpoon Therapeutics stock.

Harpoon Therapeutics share dividends

We're not expecting Harpoon Therapeutics to pay a dividend over the next 12 months.

Harpoon Therapeutics share price volatility

Over the last 12 months, Harpoon Therapeutics's shares have ranged in value from as little as $6.32 up to $25.235. A popular way to gauge a stock's volatility is its "beta".

HARP.US volatility(beta: 0.88)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Harpoon Therapeutics's is 0.8773. This would suggest that Harpoon Therapeutics's shares are less volatile than average (for this exchange).

Harpoon Therapeutics overview

Harpoon Therapeutics, Inc. , a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company's lead tri-specific t-cell activating construct (TriTAC) product candidate is HPN424, which is in Phase I/IIa clinical trials for the treatment of metastatic castration-resistant prostate cancer. It is also developing HPN536, which is in Phase I/IIa clinical trials for the treatment of ovarian cancer and other mesothelin-expressing tumors; HPN217 that is in Phase I/II clinical trials for the treatment of multiple myeloma; and HPN328, a product candidate in Phase I/II clinical trials for the treatment of small cell lung cancer and other Delta-like canonical Notch ligand 3-expressing tumors. The company has a discovery collaboration and license agreement with AbbVie Biotechnology Ltd. to develop and commercialize products that incorporate our proprietary TriTAC platform technology together with soluble T cell receptors. Harpoon Therapeutics, Inc.

Frequently asked questions

What percentage of Harpoon Therapeutics is owned by insiders or institutions?
Currently 7.737% of Harpoon Therapeutics shares are held by insiders and 88.533% by institutions.
How many people work for Harpoon Therapeutics?
Latest data suggests 88 work at Harpoon Therapeutics.
When does the fiscal year end for Harpoon Therapeutics?
Harpoon Therapeutics's fiscal year ends in December.
Where is Harpoon Therapeutics based?
Harpoon Therapeutics's address is: 131 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
What is Harpoon Therapeutics's ISIN number?
Harpoon Therapeutics's international securities identification number is: US41358P1066
What is Harpoon Therapeutics's CUSIP number?
Harpoon Therapeutics's Committee on Uniform Securities Identification Procedures number is: 41358P106

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site